23 November, 2023
10:30 am - 11:30 am
The UK's life sciences industry is at the forefront of a competitive global market, as evidenced by the speed with which we discovered and deployed effective COVID-19 vaccines. From pioneering advancements in genomics and biotech, to revolutionising healthcare delivery systems, the UK's life sciences sector is a powerful tool for innovation and resilience. And, beyond its vital contribution to GDP, it also plays a key role in the nation's health.
The Government has long recognised the importance of this sector, publishing the 'Life Sciences Vision' in July 2021 – a strategy created in partnership industry directly. With four ambitious preconditions for success – making the NHS a better innovation partner, more investment in science and research, better use of NHS data, and improved access to capital – it was always likely to require significant spending and concerted focus.
Reform is delighted to welcome George Freeman MP, Minister for Science, Research and Innovation in the Department for Science, Innovation and Technology; Lord O'Shaughnessy, Co-Founder and Senior Partner of Newmarket Strategy; and one more panellist to be announced to this panel to discuss the next steps for the Life Sciences Vision.
Please note there will also an opportunity to network over tea and coffee after the event.
If you would like to attend, please email firstname.lastname@example.org
Please note that due to limited availability, registration does not automatically guarantee attendance at this event.
This event is kindly supported by Moderna.